FWD 2 Botanical Adulterants Monitor


Northern Illinois Court District Class Action Lawsuit Based on NYAG Investigation Settled by Target, Walgreens, and Walmart

Over two years after New York Attorney General Eric Schneiderman sent cease-and-desist orders to the four retailers GNC, Target, Walgreens, and Walmart for allegedly selling adulterated herbal dietary supplements based on the results of a flawed and widely criticized DNA barcoding investigation into the authenticity of herbal dietary supplements, Target, Walmart, and Walgreens settled a multi-district lawsuit that was based on the results of the NY AG’s investigation.1 The lawsuit, a consolidation of cases initiated by attorneys of 56 consumers, alleges major fraud by the retailers, and claims, among others, that “millions of consumers across the nation have been duped by GNC, Target, Walmart, and Walgreens and have spent years purchasing fake and fraudulent products.”2 GNC, which initially was a defendant in this litigation, entered early into an agreement with the NY AG, in which Schneiderman’s office explicitly stated that “NY AG found no evidence in the course of its investigation that GNC deviated from the federal Food and Drug Administration (FDA) current Good Manufacturing Practices (cGMPs) rules or standard industry practice in the production of the tested supplements,” which eventually led to the dismissal of GNC from the lawsuits. (The GNC herb supplements, which were subject of the initial action by the NY AG, were allowed to be sold immediately after the agreement was signed, without any modification of the ingredients or product labels.) Details of the settlement between the plaintiffs and Target, Walgreens, and Walmart are not known.

Comment: With this settlement, it is unlikely that the questions about the contents of the herbal dietary supplements investigated by the NY AG will ever be answered. Nevertheless, the actions by the NY AG have left their mark on the botanical dietary supplements industry in the United States, especially the requirement for those companies that entered a settlement with the NY AG and agreed to use genetic testing for plant identification. While the benefits and limitations of genetic methods are generally known in the botanical industry, the benefit of such testing on crude raw materials in cases where taxonomic or macroscopic identification provide adequate documentation of identity is questionable.

References

  1. Long J. Target, Walgreens, and Walmart settle class action lawsuit initiated by NYAG investigation. Natural Products Insider [online]. July 26, 2017. Available at: https://www.naturalproductsinsider.com/blogs/insider-law/2017/07/walmart-target-settle-herbal-supplements-class-ac.aspx. Accessed October 20, 2017.
  2. Hagens Berman files class-action lawsuit against Walmart, Walgreens, Target and GNC over reportedly fraudulent supplements. BusinessWire. February 6, 2015. Available at: http://www.businesswire.com/news/home/20150206005876/en/Hagens-Berman-Files-Class-Action-Lawsuit-Walmart-Walgreens. Accessed October 20, 2017.